The 17ᵗʰ Biennale Monégasque de Cancérologie will return to the Grimaldi Forum from 27ᵗʰ to 30ᵗʰ January, with a landmark focus on paediatric oncology and artificial intelligence in cancer care.

Held under the High Patronage of Prince Albert II, the Biennale is set to become a key platform for global leaders in cancer research. One of the most anticipated moments will be the unveiling of early results from MEPENDAX, the first paediatric clinical trial developed from work conducted in Monaco. Presented by Professor Nicolas André of APHM Marseille, the study offers new therapeutic hope for children facing rare and aggressive brain tumours.

The paediatric session, shaped in part by the efforts of Fondation Flavien, will gather national and international experts whose work is driving the science of today and tomorrow. “My pride is having brought them all together for the children,” said organiser Denis Maccario, who described the session as both deeply human and scientifically ambitious.

Also taking the stage will be Dr Raphaël Rodriguez of the Institut Curie, whose groundbreaking research on metastases has gained worldwide attention.

The event will close with a cocktail evening on Friday 30ᵗʰ January.

Stay updated with Monaco Life: sign up for our free newsletter, catch our podcast on Spotify, and follow us across Facebook,  Instagram, LinkedIn, and Tik Tok.